Plasma protein profiles in early asthmatic responses to inhalation allergen challenge

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 64, Issue 1, 2009, Pages 47-54

  Rhim, T ^a   Choi, Y S ^a   Nam, B Y ^a   Uh, S T ^a,b,c   Park, J S ^a,b,c   Kim, Y H ^a,b,c   Paik, Y K ^d   Park, C S ^a,b,c  

^a Genome Research Center for Allergy and Respiratory Diseases

^b Division of Allergy and Respiratory Medicine

^c Soonchunhyang University   (South Korea)

^d Yonsei University   (South Korea)

Author keywords

Antigen; Asthma; Challenge; IPR; Plasma; Proteomics

Indexed keywords

APOLIPOPROTEIN E3; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3D; COMPLEMENT COMPONENT C4A; FIBRINOGEN; GAMMA FIBRINOGEN; HOUSE DUST ALLERGEN; HUMAN SERUM ALBUMIN; PLASMA PROTEIN; PREALBUMIN; SERUM ALBUMIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOPHAGOIDES PTERONYSSINUS; DISEASE PREDISPOSITION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNE RESPONSE; MALE; MASS SPECTROMETRY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANTIGENS, DERMATOPHAGOIDES; ASTHMA; BIOLOGICAL MARKERS; BLOOD PROTEINS; BLOTTING, WESTERN; BRONCHIAL PROVOCATION TESTS; COMPLEMENT C3; FIBRINOGEN; GENE EXPRESSION REGULATION; MASS SPECTROMETRY; PROTEOMICS;

EID: 58149110936     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2008.01817.x     Document Type: Article

References (44)

1. Cambell P, Weiss U, editors. Allergy and asthma. Nature 1999 402 : B1 B38.
2. Fish JE, Peters SP Bronchial challenge testing. In : Adkinson NF Jr, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Simons FER, editors. Middleton's allergy principle and practice, 6th edn. Philadelphia : Mosby, Inc., 2003 : 657 670.
3. Robinson DS, Hamid Q, Bentley A, Ying S, Kay AB, Durham SR. Activation of CD41 T cells, increased Th-2 type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation in atopic asthmatics. J Allergy Clin Immunol 1993 92 : 313 324.
4. Sheth KK, Lemanske RF. The early and late asthmatic response to allergen. In : Holgate ST, Busse WW, editors. Lung biology in health and disease. Inflammatory mechanisms in asthma. New York, NY : Marcel Dekker, 1998 : 805 821.
5. Bonavia M, Crimi E, Quaglia A, Brusasco V. Comparison of early and late asthmatic responses between patients with allergic rhinitis and mild asthma. Eur Respir J 1996 9 : 905 909.
6. van der Veen MJ, Lopuhaa CE, Aalberse RC, Jansen HM, van der Zee JS. Bronchial allergen challenge with isolated major allergens of Dermatophagoides pteronyssinus: the role of patient characteristics in the early asthmatic response. J Allergy Clin Immunol 1998 102 : 24 31.
7. Cockcroft DW, Murdock KY, Kirby J, Hargreave F. Prediction of airway responsiveness to allergen from skin sensitivity to allergen and airway responsiveness to histamine. Am Rev Respir Dis 1987 135 : 264 267.
8. Bingham CO, Austen KF. 2000. Mast cell responses in the development of asthma. J Allergy Clin Immunol 1976 58 : 647 656.
9. Dahlén SE, Hansson G, Hedqvist P, Björck T, Granström E, Dahlén B. Allergen challenge of lung tissue from asthmatics elicits bronchial contraction that correlates with the release of leukotrienes C4, D4, and E4. Proc Natl Acad Sci USA 1983 80 : 1712 1716.
10. Miadonna A, Tedeschi A, Leggieri E, Brasca C, Folco GC, Sala A et al. Mediators and allergic inflammation of human airways. Respiration 1988 54 (Suppl. 1 78 83.
11. Wenzel SE, Westcott JY, Smith HR, Larsen GL. Spectrum of prostanoid release after bronchoalveolar allergen challenge in atopic asthmatics and in control groups. An alteration in the ratio of bronchoconstrictive to bronchoprotective mediators. Am Rev Respir Dis 1989 139 : 450 457.
12. O'Sullivan S, Roquet A, Dahlén B, Dahlén S, Kumlin M. Urinary excretion of inflammatory mediators during allergen-induced early and late phase asthmatic reactions. Clin Exp Allergy 1998 28 : 1332 1339.
13. Lauredo IT, Forteza RM, Botvinnikova Y, Abraham WM. Leukocytic cell sources of airway tissue kallikrein. Am J Physiol Lung Cell Mol Physiol 2004 286 : L734 L740.
14. Terada M, Kelly EA, Jarjour NN. Increased thrombin activity after allergen challenge: a potential link to airway remodeling? Am J Respir Crit Care Med 2004 169 : 373 377.
15. HuangFu T, Lim LH, Chua KY. Efficacy evaluation of Der p 1 DNA vaccine for allergic asthma in an experimental mouse model.1. Vaccine 2006 24 : 4576 4581.
16. Joo JH, Park SJ, Park SW, Lee JH, Kim DJ, Uh ST et al. Clinical features of eosinophilic bronchitis. Korean J Intern Med 2002 17 : 31 37.
17. Tonge R, Shaw J, Middleton B, Rowlinson R, Rayner S, Young J et al. Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics 2001 1 : 377 396.
18. Shevchenko A, Wilm M, Vorm O, Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996 68 : 850 858.
19. Marks GB, Tovey ER, Toelle BG, Wachinger S, Peak JK, Woolcock AJ. Mite allergen (Der p 1) concentration in houses and its relation to the presence and severity of asthma in a population of Sydney schoolchildren. J Allergy Clin Immunol 1995 96 : 441 448.
20. Krug N, Tschernig T, Erpenbeck VJ, Hohlfeld JM, Köhl J. Complement factors C3a and C5a are increased in bronchoalveolar lavage fluid after segmental allergen provocation in subjects with asthma. Am J Respir Crit Care Med 2001 164 : 1841 1843.
21. Park JW, Taube C, Joetham A, Takeda K, Kodama T, Dakhama A et al. Complement activation is critical to airway hyper-responsiveness after acute ozone exposure. Am J Respir Crit Care Med 2004 169 : 726 732.
22. Polack FP, Teng MN, Collins PL, Prince GA, Exner M, Regele H et al. A role for immune complexes in enhanced respiratory syncytial virus disease. J Exp Med 2002 196 : 859 865.
23. Shima M, Adachi M. Effects of environmental tobacco smoke on serum levels of acute phase proteins in schoolchildren. Prev Med 1996 25 : 617 624.
24. Walters DM, Breysse PN, Schofield B, Wills-Karp M. Complement factor 3 mediates particulate matter-induced airway hyper-responsiveness. Am J Respir Cell Mol Biol 2002 27 : 413 418.
25. Lee SH, Rhim T, Choi YS, Min JW, Kim SH, Cho SY et al. Complement C3a and C4a increased in plasma of patients with aspirin-induced asthma. Am J Respir Crit Care Med 2006 173 : 370 378.
26. Maruo K, Akaike T, Ono T, Okamoto T, Maeda H. Generation of anaphylatoxins through proteolytic processing of C3 and C5 by house dust mite protease. J Allergy Clin Immunol 1997 100 : 253 260.
27. Farrell DH. Pathophysiologic roles of the fibrinogen gamma chain. Curr Opin Hematol 2004 11 : 151 155.
28. Doolittle RF. X-ray crystallographic studies on fibrinogen and fibrin. J Thromb Haemost 2003 1 : 1559 1565.
29. Mosesson MW. Fibrinogen gamma chain functions. J Thromb Haemost 2003 1 : 231 238.
30. Ugarova TP, Lishko VK, Podolnikova NP, Okumura N, Merkulov SM, Yakubenko VP et al. Sequence gamma 377-395(P2), but not gamma 190-202(P1), is the binding site for the alpha MI-domain of integrin alpha M beta 2 in the gamma C-domain of fibrinogen. Biochemistry 2003 42 : 9365 9373.
31. Sahni A, Francis CW. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood 2000 96 : 3772 3778.
32. Sahni A, Altland OD, Francis CW. FGF-2 but not FGF-1 binds fibrin and supports prolonged endothelial cell growth. J Thromb Haemost 2003 1 : 1304 1310.
33. Sahni A, Guo M, Sahni SK, Francis CW. Interleukin-1beta but not IL-1alpha binds to fibrinogen and fibrin and has enhanced activity in the bound form. Blood 2004 104 : 409 414.
34. Chung DW, Davie EW. Gamma and gamma' chains of human fibrinogen are produced by alternative mRNA processing. Biochemistry 1984 23 : 4232 4236.
35. Lovely RS, Falls LA, Al-Mondhiry HA, Chambers CE, Sexton GJ, Ni H et al. Association of gammaA/gamma' fibrinogen levels and coronary artery disease. Thromb Haemost 2002 88 : 26 31.
36. Falls LA, Farrell DH. Resistance of rA/r fibrin clots to fibrinolysis. J Biol Chem 1997 272 : 14251 14256.
37. Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J 1990 265 : 621 636.
38. Knauer KA, Lichtenstein LM, Adkinson NF Jr., Fish JE. Platelet activation during antigen-induced airway reactions in asthmatic subjects. N Engl J Med 1981 304 : 1404 1407.
39. Yamamoto H, Nagata M, Tabe K, Kimura I, Kiuchi H, Sakamoto Y et al. The evidence of platelet activation in bronchial asthma. J Allergy Clin Immunol 1993 91 : 79 87.
40. Tutluoglu B, Gurel CB, Ozdas SB, Musellim B, Erturan S, Anakkaya AN et al. Platelet function and fibrinolytic activity in patients with bronchial asthma. Clin Appl Thromb Hemost 2005 11 : 77 81.
41. Pitchford SC, Momi S, Giannini S, Casali L, Spina D, Page CP et al. Platelet P-selectin is required for pulmonary eosinophil and lymphocyte recruitment in a murine model of allergic inflammation. Blood 2005 105 : 2074 2081.
42. Kowal K, Pampuch A, Kowal-Bielecka O, DuBuske LM, Bodzenta- Łukaszyk A. Platelet activation in allergic asthma patients during allergen challenge with Dermatophagoides pteronyssinus. Clin Exp Allergy 2006 36 : 426 432.
43. Sillaber C, Baghestanian M, Bevec D, Willheim M, Agis H, Kapiotis S et al. The mast cell as site of tissue-type plasminogen activator expression and fibrinolysis. J Immunol 1999 162 : 1032 1041.
44. Mekori YA, Galli SJ. [125I] fibrin deposition occurs at both early and late intervals of IgE-dependent or contact sensitivity reactions elicited in mouse skin. Mast cell-dependent augmentation of fibrin deposition at early intervals in combined IgE-dependent and contact sensitivity reactions. J Immunol 1990 145 : 3719 3727.